Advertisement

Topics

New Hikma CEO Eyes M&A, Upbeat Despite Generic Advair Woes

10:04 EDT 14 Mar 2018 | SCRIP

 Sigurdur Olafsson is impressed with the balance sheet he has inherited at Hikma and said he is looking forward to...

      

Related Stories

 

Original Article: New Hikma CEO Eyes M&A, Upbeat Despite Generic Advair Woes

NEXT ARTICLE

More From BioPortfolio on "New Hikma CEO Eyes M&A, Upbeat Despite Generic Advair Woes"

Advertisement
Quick Search
Advertisement
Advertisement